Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,605 | N/A | 874 | 737 | 728 |
| Marketable Securities | 18,837 | N/A | 31,485 | 31,247 | 31,936 |
| Receivables | 251 | N/A | N/A | N/A | N/A |
| TOTAL | $31,693 | $N/A | $32,797 | $32,390 | $33,167 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 15,012 | 0 | 15,012 | 15,835 | 15,883 |
| TOTAL | $15,012 | $N/A | $15,012 | $15,835 | $15,883 |
| Total Assets | $46,705 | $N/A | $47,809 | $48,225 | $49,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 134 | 0 | 169 | 83 | 133 |
| Accrued Expenses | N/A | N/A | N/A | 223 | 352 |
| Other current liabilities | 2,446 | N/A | 3,310 | 3,390 | 2,872 |
| TOTAL | $2,580 | $N/A | $3,479 | $3,696 | $3,357 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 44,125 | 0 | 44,330 | 44,529 | 45,693 |
| TOTAL | $44,125 | $N/A | $44,330 | $44,529 | $45,693 |
| Total Liabilities | $46,705 | $N/A | $47,809 | $48,225 | $49,050 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,235 | 8,235 | 8,235 | 8,235 | 8,235 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $46,705 | $0 | $47,809 | $48,225 | $49,050 |